about
Hepatic arterial embolization in patients with neuroendocrine tumorsGamma-enolase: a well-known tumour marker, with a less-known role in cancerThe biological characterization of neuroendocrine tumors: the role of neuroendocrine markersPrimary hepatic neuroendocrine tumor: A case reportPrimary intracranial neuroendocrine tumor with ectopic adrenocorticotropic hormone syndrome: A rare and complicated case report and literature review.Diagnosis and treatment of carcinoid tumors.Histone H1x is highly expressed in human neuroendocrine cells and tumours.Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescenceLess common neoplasms of the pancreas.Multimodal management of neuroendocrine liver metastases.Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature.Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)A post-transcriptional mechanism pacing expression of neural genes with precursor cell differentiation status.From basic to clinical research in gastroenteropancreatic neuroendocrine tumor disease -- the clinician-scientist perspective.Case Report of Contrast-Enhanced Ultrasound Features of Primary Hepatic Neuroendocrine Tumor: A CARE-Compliant ArticleCorrelation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic strokePeptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor CellsOsteopontin -- a promising biomarker for cancer therapy.Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation.Comparison of immunoreactive score, HER2/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms.Serum neuron-specific enolase as an early predictor of delayed neuropsychiatric sequelae in patients with acute carbon monoxide poisoning.
P2860
Q21198838-3184F17B-5674-421A-A2D0-6E6DA56BFD94Q26781703-1B4E8C1E-82FE-47D3-A3A8-DC18AA5C99D6Q28275872-A8565958-2761-424D-BF1D-9AD53A1E2B88Q30381819-8D02DF6F-10F4-4B95-98F5-D7E92D3820C0Q31109740-BF3F118F-2219-4BE1-9053-634FE654E327Q33196127-F36DE117-C321-406E-9E9D-CC156D8EA1DFQ33395865-FFF19B27-ABE0-4B72-B586-D92DDF5B147DQ33759991-5F60CA36-BD6C-4BD0-8950-01EEEC7CF2B7Q33868386-BA2678E3-76B2-4111-B234-42279C58AD75Q34528199-2191BC1F-B262-484D-83D1-7BAC8C89BB94Q35169422-2529FD43-1A87-4ADA-9A0D-9F216E39A585Q35621231-E44CB4D4-28B8-4BEE-A5B7-CAD758026238Q35760798-9F1EDE6B-AFAE-4E6F-B269-8ED6FF0CD078Q35863576-8A94FBD7-1023-4BC8-B78C-3E2CA5CFE801Q35915032-F57D4DFD-97B6-4B46-8EEC-39C320677C5BQ36992809-CCE1C1FB-5789-40DA-A132-85D35A36D640Q37345466-42F924D1-CEA8-48FF-A7F8-36E08CCF1B03Q37611641-B0B0E849-0AFF-461F-83F7-716B39534B79Q38619009-CEE3E057-A663-4365-B7EB-E90BF23F181DQ40712159-EB2C6204-F6CD-4151-8D5D-A9614F803C59Q41496806-1FE4987F-88C8-4247-ADA1-23BCF8A45FC0Q50768854-11BD47E5-2BEF-422C-9A58-CC3C41B44185
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neuroendocrine tumor markers.
@ast
Neuroendocrine tumor markers.
@en
Neuroendocrine tumor markers.
@nl
type
label
Neuroendocrine tumor markers.
@ast
Neuroendocrine tumor markers.
@en
Neuroendocrine tumor markers.
@nl
prefLabel
Neuroendocrine tumor markers.
@ast
Neuroendocrine tumor markers.
@en
Neuroendocrine tumor markers.
@nl
P2093
P356
P1476
Neuroendocrine tumor markers.
@en
P2093
Hofland LJ
Lamberts SW
P304
P356
10.1006/FRNE.2001.0218
P577
2001-10-01T00:00:00Z